ARCHIVES

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

NIH Introduces “Modular” Gran Application And Awards

February 26, 1999

Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants

March 13, 1981